ChinaBio Today Editor Scott on China Life Sciences and IP

December 24, 2007 -- In an interview with Interfax China, Greg Scott, Executive Editor of ChinaBio® Today, discusses investing in China biopharma, comparing the merits of pharmaceutical and medical device investment in China, and discussing also the state of China's Intellectual Property protection. More details…

Back to news